Latest News for Guardant Health Stock (NASDAQ:GH)

Monday, December 04, 2023

Cancer Research UK and Guardant Health Launch Collaboration to Advance Cancer Research and Clinical Development Activities, Terms Undisclosed
Benzinga Newsdesk - Dec 4, 2023, 5:02AM

Thursday, November 30, 2023

Guardant Health To Present Data At San Antonio Breast Cancer Symposium Demonstrating Utility Of Liquid Biopsy In Biomarker Identification, Therapy Selection And Residual Disease Detection
Benzinga Newsdesk - Nov 30, 2023, 8:09AM

Tuesday, November 28, 2023

Jim Cramer: Buy This Financial Stock, 'It's Up Substantially From Where It Was In The Spring'
Lisa Levin - Nov 28, 2023, 9:00AM

Friday, November 17, 2023

Chief Technology Officer at Guardant Health Exercises Options Worth $89K
Benzinga Insights - Nov 17, 2023, 10:00AM

Wednesday, November 15, 2023

Why Is Cancer Blood Test-Focused Guardant Health Stock Trading Lower Today?
Vandana Singh - Nov 15, 2023, 2:28PM
Guardant Health shares are trading lower. The company said it intends to appeal yesterday's verdict in the U.S. District Court for the District of Delaware related to intellectual property claims brought by TwinStrand Biosciences University of Washington.
Benzinga Newsdesk - Nov 15, 2023, 12:13PM
Guardant Health To Appeal Federal District Court Verdict Related To Intellectual Property Claims
Benzinga Newsdesk - Nov 15, 2023, 3:30AM

Monday, November 13, 2023

Guardant Health shares are trading higher after Raymond James upgraded the stock from Market Perform to Outperform.
Benzinga Newsdesk - Nov 13, 2023, 12:56PM
7 Analysts Have This to Say About Guardant Health
Benzinga Insights - Nov 13, 2023, 8:00AM
Raymond James Upgrades Guardant Health to Outperform, Announces $27 Price Target
Benzinga Newsdesk - Nov 13, 2023, 7:26AM

Sunday, November 12, 2023

Guardant Health Launched Shield Blood-based Screening Test For Colorectal Cancer In S. Korea
Charles Gross - Nov 12, 2023, 7:06PM

Wednesday, November 08, 2023

Morgan Stanley Maintains Overweight on Guardant Health, Lowers Price Target to $50
Benzinga Newsdesk - Nov 8, 2023, 4:23PM

Tuesday, November 07, 2023

Cancer Test Firm Guardant Health Posts Smaller Than Expected Q3 Loss, Lifts Annual Sales Outlook
Vandana Singh - Nov 7, 2023, 11:26AM

Monday, November 06, 2023

Guardant Health Raises 2023 Revenue Guidance To $553M-$556M Vs $549.06M Est.
Benzinga Newsdesk - Nov 6, 2023, 4:50PM
Guardant Health Q3 2023 Adj EPS $(0.67) Beats $(0.95) Estimate, Sales $143.03M Beat $137.37M Estimate
Benzinga Newsdesk - Nov 6, 2023, 4:16PM
Earnings Scheduled For November 6, 2023
Benzinga Insights - Nov 6, 2023, 8:24AM

Friday, November 03, 2023

Shares of healthcare equipment and healthcare provider stocks are trading higher amid overall market strength. Strength may also be attributed to Cardinal Health after the company reported better-than-expected Q1 financial results.
Benzinga Newsdesk - Nov 3, 2023, 3:33PM

Monday, October 23, 2023

Goldman Sachs Maintains Buy on Guardant Health, Lowers Price Target to $45
Benzinga Newsdesk - Oct 23, 2023, 8:47AM
Guardant Health Announces Initial Results From The PEGASUS Trial Show Promise For Use Of Liquid Biopsy To Guide Adjuvant Treatment Of Colon Cancer
Benzinga Newsdesk - Oct 23, 2023, 4:32AM

Friday, October 20, 2023

The Latest Analyst Ratings for Guardant Health
Benzinga Insights - Oct 20, 2023, 10:00AM
Goldman Sachs Maintains Buy on Guardant Health, Lowers Price Target to $45
Benzinga Newsdesk - Oct 20, 2023, 9:42AM

Thursday, September 28, 2023

Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
Benzinga Insights - Sep 28, 2023, 11:00AM
Guardant Health shares are trading higher after Bernstein initiated coverage on the stock with an Outperform rating and $34 price target.
Benzinga Newsdesk - Sep 28, 2023, 10:20AM
Bernstein Initiates Coverage On Guardant Health with Outperform Rating, Announces Price Target of $34
Benzinga Newsdesk - Sep 28, 2023, 6:33AM

Wednesday, September 27, 2023

Guardant Health Has 'Underlying Business Strength' Says This Bullish Analyst
Priya Nigam - Sep 27, 2023, 12:17PM
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
Benzinga Insights - Sep 27, 2023, 11:00AM
Analyst Expectations for Guardant Health's Future
Benzinga Insights - Sep 27, 2023, 8:01AM
Piper Sandler Upgrades Guardant Health to Overweight, Announces $40 Price Target
Benzinga Newsdesk - Sep 27, 2023, 7:11AM

Thursday, September 21, 2023

Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
Vandana Singh - Sep 21, 2023, 7:16AM

Wednesday, September 06, 2023

Guardant Health Receives Coverage For Guardant Reveal From Geisinger Health Plan
Benzinga Newsdesk - Sep 6, 2023, 8:06AM

Tuesday, September 05, 2023

Guardant Health Receives Regulatory Approval In Japan For Guardant360 CDx As Companion Diagnostic tT ENHERTU For Treatment Of Non-Small Cell Lung Cancer Patients With HER2 Mutations
Benzinga Newsdesk - Sep 5, 2023, 8:07AM

Friday, September 01, 2023

Guardant Health Chief Medical Officer, Craig Eagle Says We Agree With The Decision, Based On The Recent Planned Interim Analysis, To Close The COBRA Study To New Enrollees
Happy Mohamed - Sep 1, 2023, 3:51PM
Guardant Health Provides Update On COBRA Study, Restates Confidence In MRD Test
Happy Mohamed - Sep 1, 2023, 3:47PM

Friday, August 18, 2023

Guardant Health shares are trading higher. Not seeing company-specific news.
Benzinga Newsdesk - Aug 18, 2023, 1:11PM

Tuesday, August 08, 2023

Piper Sandler Maintains Neutral on Guardant Health, Raises Price Target to $40
Benzinga Newsdesk - Aug 8, 2023, 3:07PM

Monday, August 07, 2023

Morgan Stanley Maintains Overweight on Guardant Health, Lowers Price Target to $55
Benzinga Newsdesk - Aug 7, 2023, 11:30AM

Friday, August 04, 2023

The Latest Analyst Ratings for Guardant Health
Benzinga Insights - Aug 4, 2023, 2:00PM
Citigroup Maintains Buy on Guardant Health, Raises Price Target to $50
Benzinga Newsdesk - Aug 4, 2023, 8:14AM

Thursday, August 03, 2023

Guardant Health Raises FY23 Revenue From $535M-$545M To $545M-$550M Vs $541.39M Est
Benzinga Newsdesk - Aug 3, 2023, 5:53PM
Guardant Health Q2 Adj EPS $(0.82) Beats $(1.18) Estimate, Sales $137.15M Beat $129.41M Estimate
Benzinga Newsdesk - Aug 3, 2023, 4:18PM
Earnings Scheduled For August 3, 2023
Benzinga Insights - Aug 3, 2023, 6:59AM

Wednesday, August 02, 2023

Preview: Guardant Health's Earnings
Benzinga Insights - Aug 2, 2023, 11:01AM

Tuesday, August 01, 2023

Guardant Resolves Pending Litigation With Illumina; Enters Into New Agreement To Advance Long-Term Commercial Partnership And Cancer Research
Benzinga Newsdesk - Aug 1, 2023, 4:48PM

Thursday, July 20, 2023

Guardant Health Receives First Commercial Payor Coverage For Guardant Reveal Test From Blue Cross And Blue Shield Of Louisiana
Happy Mohamed - Jul 20, 2023, 8:21AM

Wednesday, July 05, 2023

Guardant Health Announces Reimbursement Approval Of Guardant360 CDX Liquid Biopsy Test In Japan
Happy Mohamed - Jul 5, 2023, 8:09AM

Tuesday, May 30, 2023

Watching Guardant Health; Hearing Traders Circulate Rumor That A Large Activist Investor May Be Targeting The Co
Happy Mohamed - May 30, 2023, 9:48AM

Friday, May 26, 2023

Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2023
Benzinga Insights - May 26, 2023, 11:00AM
Analyst Ratings for Guardant Health
Benzinga Insights - May 26, 2023, 10:02AM
Guardant Health shares are trading higher after Citigroup upgraded the stock from Neutral to Buy and announced a $40 price target.
Benzinga Newsdesk - May 26, 2023, 8:26AM
Citigroup Upgrades Guardant Health to Buy, Announces $40 Price Target
Benzinga Newsdesk - May 26, 2023, 8:22AM

Open25.860	Close-
Vol / Avg.400.458K / 1.665M	Mkt Cap3.024B
Day Range25.200 - 25.890	52 Wk Range20.670 - 50.420

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Guardant Health Stock (NASDAQ:GH)

Monday, December 04, 2023

Thursday, November 30, 2023

Tuesday, November 28, 2023

Friday, November 17, 2023

Wednesday, November 15, 2023

Monday, November 13, 2023

Sunday, November 12, 2023

Wednesday, November 08, 2023

Tuesday, November 07, 2023

Monday, November 06, 2023

Friday, November 03, 2023

Monday, October 23, 2023

Friday, October 20, 2023

Thursday, September 28, 2023

Wednesday, September 27, 2023

Thursday, September 21, 2023

Wednesday, September 06, 2023

Tuesday, September 05, 2023

Friday, September 01, 2023

Friday, August 18, 2023

Tuesday, August 08, 2023

Monday, August 07, 2023

Friday, August 04, 2023

Thursday, August 03, 2023

Wednesday, August 02, 2023

Tuesday, August 01, 2023

Thursday, July 20, 2023

Wednesday, July 05, 2023

Tuesday, May 30, 2023

Friday, May 26, 2023